NCT02831634 A Feasibility Study to Identify T-cell Responses to Neo-epitopes in Tumor Invaded Lymph Nodes (NeoEpitope) Status COMPLETED Phase NA
NCT02791334 A Study of Anti-PD-L1 Checkpoint Antibody (LY3300054) Alone and in Combination in Participants With Advanced Refractory Solid Tumors Status COMPLETED Phase PHASE1
NCT02355587 Five Year Study to Track Use of DecisionDX-Melanoma Test in Patients With Cutaneous Melanoma and Associated Patient Outcomes Status TERMINATED Phase N/A
NCT02355574 5-year Study to Track Clinical Application of DecisionDx-Melanoma Gene Expression Profile Assay Results Status TERMINATED Phase N/A
NCT02288897 PV-10 vs Chemotherapy or Oncolytic Viral Therapy for Treatment of Locally Advanced Cutaneous Melanoma Status TERMINATED Phase PHASE3
NCT02129075 A Vaccine (CDX-1401) With or Without a Biologic Drug (CDX-301) for the Treatment of Patients With Stage IIB-IV Melanoma Status COMPLETED Phase PHASE2
NCT01729663 Phase II/III Clinical Study CSF470 Plus BCG Plus GM-CSF vs IFN Alpha 2b in Stage IIB, IIC and III Melanoma Patients Status UNKNOWN Phase PHASE2/PHASE3
NCT01728051 Expanded Access Study of Melphalan With Delcath CS-PHP System in Patients With Ocular/Cutaneous Melanoma Mets to Liver Status NO_LONGER_AVAILABLE Phase N/A
NCT01444560 miRNA Machinery in Melanoma, Melanoma Metastases and Benign Melanocytic Naevi Status COMPLETED Phase N/A
NCT00679289 Phase II Study of KW2871 Combined With High Dose Interferon-α2b in Patients With Metastatic Melanoma Status COMPLETED Phase PHASE2